Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Fioredda
Francesca
F
Giacchino
Mareva
M
Castagnola
Elio
E
D000293:Adolescent; D000917:Antibody Formation / Q000502:physiology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000276:immunology*; D006801:Humans; D007117:Immunization, Secondary; D016867:Immunocompromised Host; D007938:Leukemia / Q000188:drug therapy / Q000276:immunology*; D008457:Measles / Q000276:immunology / Q000517:prevention & control; D022542:Measles-Mumps-Rubella Vaccine / Q000008:administration & dosage / Q000276:immunology*; D009107:Mumps / Q000276:immunology / Q000517:prevention & control; D011051:Poliomyelitis / Q000276:immunology / Q000517:prevention & control; D011055:Poliovirus Vaccine, Oral / Q000008:administration & dosage / Q000276:immunology*; D012409:Rubella / Q000276:immunology / Q000517:prevention & control; D013742:Tetanus / Q000276:immunology / Q000517:prevention & control; D013745:Tetanus Toxoid / Q000008:administration & dosage / Q000276:immunology*; D014611:Vaccination
D017325:Hepatitis B Vaccines; D022542:Measles-Mumps-Rubella Vaccine; D011055:Poliovirus Vaccine, Oral; D013745:Tetanus Toxoid